Iana Gennadievna Nadeliaeva

Dr. Iana Gennadievna Nadeliaeva


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Larisa SuturinaLarisa Suturina
Larisa Suturina
DLDaria Lizneva
Daria Lizneva
AAAlina Atalyan
Alina Atalyan
LLLyudmila Lazareva
Lyudmila Lazareva
ABAleksey Belskikh
Aleksey Belskikh
RARicardo Azziz
Ricardo Azziz
Androgen assessment is a key element for diagnosing polycystic ovary syndrome (PCOS), and defining a “normal” level of circulating androgens is critical for epidemiological studies. We determined the upper normal limits (UNLs) for androgens in a population-based group of premenopausal “healthy control” women, overall and by ethnicity (Caucasian and Asian), in the cross-sectional Eastern Siberia PCOS Epidemiology and Phenotype (ESPEP) Study (ClinicalTrials.gov ID: NCT05194384) conducted in 2016–2019. Overall, we identified a “healthy control” group consisting of 143 healthy premenopausal women without menstrual dysfunction, hirsutism, polycystic ovaries, or medical disorders. We analyzed serum total testosterone (TT) by using liquid chromatography with tandem mass spectrometry (LC-MS/MS), and DHEAS, sex-hormone-binding globulin (SHBG), TSH, prolactin, and 17-hydroxyprogesterone (17OHP) were assessed with an enzyme-linked immunosorbent assay (ELISA). The UNLs for the entire population for the TT, free androgen index (FAI), and DHEAS were determined as the 98th percentiles in healthy controls as follows: 67.3 (95% confidence interval (CI): 48.1, 76.5) ng/dl, 5.4 (3.5, 14.0), and 355 (289, 371) μg/dl, respectively. The study results demonstrated that the UNLs for TT and FAI varied by ethnicity, whereas the DHEAS UNLs were comparable in the ethnicities studied.

4 July 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Larisa SuturinaLarisa Suturina
Larisa Suturina
ESEldar M. Sharifulin
Eldar M. Sharifulin
MSMaharam A. Sharifulin
Maharam A. Sharifulin
LLLyudmila Lazareva
Lyudmila Lazareva
IDIrina Nikolaevna Danusevich
Irina Nikolaevna Danusevich
INIana Gennadievna Nadeliaeva
Iana Gennadievna Nadeliaeva
Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of virilization, which has an erased picture in postmenopausal women. LCTs require differential diagnosis with other causes of hyperandrogenism. We present the clinical case of a 55-year-old Russian postmenopausal patient with LCTs of the right ovary, significantly increased levels of androgens, and rapidly progressive clinical signs of hyperandrogenism. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the androgen indices reached average values by the first and third month after surgery. This case demonstrates that LCTs are often benign with a good prognosis and normalization of the clinical and laboratory manifestations of hyperandrogenism after surgical treatment. The type of surgery performed (bilateral salpingo-oophorectomy rather than unilateral) is recommended as the treatment of choice for LCTs in postmenopausal patients.

29 December 2022 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
Larisa SuturinaLarisa Suturina
Larisa Suturina
ABA. V. Belskikh
A. V. Belskikh
LSL. F. Sholokhov
L. F. Sholokhov
MRM. A. Rashidova
M. A. Rashidova
IDIrina Nikolaevna Danusevich
Irina Nikolaevna Danusevich
ЯНЯ. Г. Наделяева
Я. Г. Наделяева
Testosterone assessment is essential for detecting biochemical hyperandrogenism, one of the important diagnostic criteria of polycystic ovary syndrome (PCOS) both in clinical practice and in epidemiological studies. Currently, tandem liquid chromatography-mass spectrometry (LC-MS/MS) is the most preferred technique to measure testosterone level in women. Its validation is important to reproducibility of androgen tests results for clinical practice and for epidemiological studies of the prevalence PCOS.The aim of the study. To develop and validate a method for determining total testosterone in blood serum using highly efficient LC-MS/MS to assess androgenemia in the epidemiological study of the prevalence of PCOS and its phenotypes in Eastern Siberia (ESPEP STUDY).Materials and methods. We determined a total testosterone level in serum blood using triple quadrupole mass spectrometer LCMS-8060 (Shimadzu, Japan). The protocol of technique was developed using self-prepared purified human testosteronefree serum with a known concentration of analyzed compound. We used the serum samples of women of reproductive age to test the developed method.Results. Optimum chromatographic conditions were obtained with a Kromasil 100-2.5-C18 column (2.1 mm × 100 mm; AkzoNobel, Netherlands), and an isocratic elution mode using a mobile phase consisting of acetonitrile and 0.1 % aqueous solution of formic acid. The total flow rate was 0.35 ml/min. The lower limit of quantification was 5 ng/dl with an average accuracy of 100.2 %. During the approbation of the method in a test population sample of 1138 premenopausal women (mean age – 34.3 ± 6.3 years), the median testosterone concentration was 26.9 ng/dl.Conclusion. It was found that the proposed method for determining testosterone in blood serum has acceptable linearity and reproducibility and meets the requirements for bioanalytical methods under the regulatory documentation. This method can be used for clinical practice and epidemiological study of the prevalence of PCOS.

29 September 2023 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
LBL. V. Belenkaia
L. V. Belenkaia
Larisa SuturinaLarisa Suturina
Larisa Suturina
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
AAAlina Atalyan
Alina Atalyan
LLLyudmila Lazareva
Lyudmila Lazareva
ЯНЯ. Г. Наделяева
Я. Г. Наделяева
The aim of the study. To determine the age limit of the initial manifestations of the metabolic syndrome in women of reproductive age of the Caucasian and Asian ethnic groups. Materials and methods. The study included women of reproductive age of the Russian and Buryat ethnic groups (n = 1231). We carried out general clinical examination, studied glycemia levels and lipid metabolism indicators. The analysis of the components of the metabolic syndrome was performed taking into account age characteristics and ethnicity. Threshold values for the age of metabolic disorders manifestation were determined. Results. It was found that the main components of the metabolic syndrome in women of reproductive age of the Russian and Buryat ethnic groups were a decrease in high-density lipoprotein (HDL), an increase in waist circumference, and an increase in blood pressure. The age-related determinants of the metabolic syndrome in the population of women of reproductive age in the Baikal region were determined. It was shown that the age-related determinants of the metabolic syndrome in Caucasian and Asian women do not differ significantly and amount to 33.5 years (95% confidence interval (95% CI): 32.5; 38.5) and 36.5 years (95% CI: 27.5; 52.5), respectively. A universal critical age value was determined as 34.5 years (95% CI: 32.5; 38.5), which is associated with a significant increase in the prevalence of the metabolic syndrome in accordance with the ATP III criteria. The ranking of metabolic syndrome criteria in the studied groups revealed the following order of their occurrence: the decrease in HDL index prevailed, followed by the increase in waist circumference, blood pressure, glucose and triglycerides; no dependence on the ethnicity was found. Conclusion. When assessing the age-related determinants of the metabolic syndrome in the mixed Caucasoid-Asian group, it is advisable to use universal approaches, taking into account the cut-off point of age, which is 34.5 years. The determination of age criteria for the correct classification of patients with respect to the manifestations of the metabolic syndrome is necessary to analyze the contribution of the age factor to the implementation of various metabolic syndrome predictors, to develop prognostic models, and to use effective age-determined markers of metabolic disorders.

1 January 2025 in Doctor.Ru
Verified
Journal Article
Open access
SPScientific Сentre for Family Health and Human Reproduction Problems
Scientific Сentre for Family Health and Human Reproduction Problems
INIana Gennadievna Nadeliaeva
Iana Gennadievna Nadeliaeva
RIRussian Federation Irkutsk
Russian Federation Irkutsk
IDI.N. Danusevich
I.N. Danusevich
Aim. To analyze the awareness of menopause-related issues among the female population. Key points. Domestic and foreign scientific literature was analyzed using the following keywords: menopause, menopausal syndrome, premenopause, postmenopause, quality of life, rural population, urban population. The review is based on the following databases: Pubmed, MedLine, The Cochrane Library, CyberLeninka, Elibrary.ru and others. The material is based on the data of review articles, clinical studies, meta-analyses. Various aspects of menopause, especially its impact on women's quality of life and long-term consequences of estrogen deficiency (cardiometabolic risks, osteoprosis, etc.) require close attention of researchers. Conclusion. Women living in rural areas tend to be less aware of the peculiarities of the course of menopause, its impact on quality of life and long-term consequences of estrogen deficiency. The results of the conducted search demonstrate the relationship between living conditions, availability of information, medical care and peculiarities of peri-/postmenopause period. The urgent tasks of doctors are to raise awareness of patients and timely prevention of complications of the menopausal period. Keywords: menopause, menopausal syndrome, premenopause, postmenopause, quality of life, rural population, urban population.

22 November 2024 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
LBL. V. Belenkaia
L. V. Belenkaia
SKS. I. Kolesnikov
S. I. Kolesnikov
LSL. F. Sholokhov
L. F. Sholokhov
IDIrina Nikolaevna Danusevich
Irina Nikolaevna Danusevich
ЯНЯ. Г. Наделяева
Я. Г. Наделяева
Background. Metabolic syndrome (MS) with hyperandrogenism comorbidity in women is considered a common concept; however, the contribution of the neuroendocrine regulation system indicators to this in reproductive age remains unclear.The aim. To analyze the activity of neuroendocrine regulation system in women of reproductive age of different ethnic groups with metabolic syndrome associated with hyperandrogenism.Materials and methods. The groups of women with MS of Russian (n = 209) and Buryat (n = 84) ethnic groups and a group of women with MS and polycystic ovary syndrome (PCOS) of Russian (n = 23) and Buryat (n = 10) ethnic groups were formed.Results. In women of reproductive age of the Russian ethnic group with MS and PCOS the study noted higher levels of anti-Müllerian hormone (AMH) (p = 0.030), testosterone (Ts) (p = 0.026), free androgen index (FAI) (p < 0.0001), dehydroepiandrosterone sulfate (DHEA-S) (p < 0.0001), and reduced levels of sex hormone-binding globulin (SHBG) (p < 0.0001) in relation to the control; in relation to the group with MS, we discovered increased values of AMH (p < 0.001), Ts (p = 0.030), FAI (p < 0.001), DHEA-S (p < 0.0001), and decreased values of SHBG (p = 0.001). In women of the Buryat ethnic group with MS and PCOS the study recorded increased values of AMH (p = 0.045), Ts (p = 0.002), FAI (p < 0.0001), DHEA-S (p = 0.033), decreased SHBG (p = 0.016) and 17-OH-progesterone (p = 0.027) levels in comparison with the control; in comparison with the group with MS we noted a higher level of DHEA-S (p = 0.006) and a decreased level of SHBG (p = 0.028).Conclusion. Women with metabolic syndrome associated with hyperandrogenism showed more intense changes in the neuroendocrine regulation system relative to control values regardless of ethnicity. In Russian women, the combined syndrome (MS with PCOS) was accompanied by a greater number of hormonal changes compared to the monosyndrome (MS) than in Buryat women. The data obtained indicate the need to assess and control the content of these metabolites in women with MS and PCOS, taking into account ethnicity.